PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
05-Jul-2024 HUTCHMED Announces NDA Acceptance in China for Tazemetostat for the Treatment of Relapsed or Refractory Follicular Lymphoma with Priority Review Status HUTCHMED
05-Jul-2024 Anacura acquires OHMX.bio, adding multi-omics for drug discovery and diagnostics to its services. Anacura
03-Jul-2024 BC Platforms Announces Appointment of New Chairman, Alex Dickinson BC Platforms
03-Jul-2024 LEO Pharma, Allergy UK and Expert Taskforce Uncover the Real Burden of Living with Chronic Hand Eczema (CHE) in New Report LEO Pharma
03-Jul-2024 Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China Medigene AG
03-Jul-2024 Pneumagen Highlights Broad-Spectrum Antiviral Activity of First-in-Class Intranasal Drug Neumifil in New Publication Pneumagen
03-Jul-2024 Agreement to Explore Optimer Vehicles for Targeted Delivery of siRNA Aptamer Group plc
03-Jul-2024 Syncona portfolio company Beacon Therapeutics raises $170 million in a Series B financing Syncona Limited
02-Jul-2024 Almirall launches Act4Impact – its updated sustainability strategy setting ambitious targets for 2030 Almirall
02-Jul-2024 Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment of chronic refractory gout Sob
02-Jul-2024 Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325 Mission Therapeutics
02-Jul-2024 ramarketing strengthens AI capabilities with key leadership appointments ramarketing
02-Jul-2024 Clinigen appoints Fernando Ballester as Chief Financial Officer Clinigen
02-Jul-2024 Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325 Mission Therapeutics
02-Jul-2024 Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma Biotherapeutics, Inc.
01-Jul-2024 New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses Teva Pharmaceutical Industries Ltd
28-Jun-2024 New number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma AB
28-Jun-2024 Almirall’s Ilumetri® (tildrakizumab) restores and maintains wellbeing of patients with moderate-to-severe plaque psoriasis to the levels of the general population for up to 1 year[i] Almirall
28-Jun-2024 Lindus Health Launches Bespoke “All-in-One Medical Device CRO” Offering for Medical Device Clinical Trials Lindus Health
27-Jun-2024 NICE recommends CSL Behring’s HEMGENIX® (etranacogene dezaparvovec) as the first single infusion gene therapy for adults with severe or moderately severe haemophilia B without a history of FIX inhibitors for reimbursement via a managed access agreement, recognising the treatment as cost-effective in England. CSL Behring